A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...

In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...

Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step closer to hitting the ...

Zepbound belongs to a class of drugs called dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor ... They can look for other factors that may be contributing ...

So how does Wegovy work ... Let's look at what the science says. Wegovy is a brand name for the medication semaglutide. Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1RA).

Opko Health Inc. and Entera Bio Ltd. have entered into a collaboration and license agreement to advance an oral dual agonist GLP-1/glucagon peptide as a once-daily tablet into the clinic for patients ...

“These findings help shape our understanding of the safety profile of GLP-1 RAs, aligning with the growing body of observational data that does not suggest an increased risk of suicide and/or ...

A liraglutide injection is a glucagon-like peptide-1 (GLP-1 ... patients with a more accessible GLP-1 treatment option, and we look forward to delivering it to our customers as quickly as possible ...